ROSEN, LEADING TRIAL ATTORNEYS, Encourages BioVie Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – BIVI
NEW YORK, Jan. 29, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioVie Inc. (NASDAQ: BIVI) between August 5, 2021 and November 29, 2023, both dates inclusive (the “Class Period”), of the important March 19, 2024
Mexico Remittance Market Witnesses Growth – In-Depth Analysis of Business and Consumer Trends to 2028
DUBLIN, Jan. 29, 2024 /PRNewswire/ — The “Mexico International Remittance Market Business and Investment Opportunities – Analysis by Transaction Value & Volume, Inbound and Outbound Transfers to and from Key States, Consumer Demographics” report has been added to Resea
Sema4.ai Raises $30.5 Million to Bring Open Source Powered AI to Mission-Critical Enterprise Work
Acquires open source automation pioneer Robocorp to ignite a new era of intelligent agents for enterprise knowledge work. ATLANTA, Jan. 29, 2024 /PRNewswire/ — Sema4.ai is on a mission to build intelligent agents that transform how knowledge workers collaborate with AI. Led by open source pion
U.S. Postal Service Board of Governors to Meet Feb. 8
WASHINGTON, Jan. 29, 2024 /PRNewswire/ — The U.S. Postal Service Board of Governors will meet Feb. 8, 2024, in open session at Postal Service headquarters, 475 L’Enfant Plaza SW, Washington, DC. The public is welcome to observe the meeting beginning at 4 p.m. EST in the Benjamin Franklin
Halozyme Announces Takeda Received European Commission Approval for HYQVIA® Co-formulated with ENHANZE® as Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
SAN DIEGO, Jan. 29, 2024 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced that Takeda received European Commission (EC) approval for HYQVIA® [Immune Globulin Infusion 10% (Human)] co-formulated with Halozyme’s ENHANZE® drug delivery tec
LeddarTech’s Board of Directors Appoints Sylvie Veilleux and Lizabeth Ardisana
QUEBEC CITY, Jan. 29, 2024 /PRNewswire/ – LeddarTech® (Nasdaq: LDTC), an automotive software company that provides patented disruptive AI-based low-level sensor fusion and perception software technology for ADAS, AD, and parking applications, today announced that its Board of Directors appoin
S&T Bancorp Announces Retirement of Steven J. Weingarten From Board of Directors
INDIANA, Pa., Jan. 29, 2024 /PRNewswire/ — S&T Bancorp, Inc. (S&T) (NASDAQ: STBA), the holding company for S&T Bank, announced today that Steven J. Weingarten, 65, has decided to retire from the board of directors and will not stand for re-election at the company’s 2024 Annua
Universal Corporation Announces Progress Towards Climate Goals
RICHMOND, Va., Jan. 29, 2024 /PRNewswire/ — Universal Corporation (NYSE:UVV) today announced that, as part of Universal’s commitment to a sustainable supply chain and minimizing greenhouse gas emissions, it has entered into a virtual power purchase agreement (VPPA) with Clearway Energy G
MAA Recognizes 30 Years as A Publicly Traded Company
GERMANTOWN, Tenn., Jan. 29, 2024 /PRNewswire/ — Mid-America Apartment Communities, Inc., (“MAA”) (NYSE: MAA) a leading multifamily real estate investment trust, announced today that the executive leadership team at MAA took part in ringing the Closing Bell® at the New York Stoc
Regal Rexnord Corporation Declares Quarterly Dividend of $.35 per share.
MILWAUKEE, Jan. 29, 2024 /PRNewswire/ — Louis Pinkham, Chief Executive Officer of Regal Rexnord Corporation (NYSE: RRX), announced that the Board of Directors, at its regular quarterly meeting held on January 29, 2024, declared a dividend of $0.35 per share. The dividend is payable on April 1
